Source link : https://newshealth.biz/health-news/drug-combo-shows-benefits-in-rare-aggressive-kidney-cancer/
(MedPage Today) — The combination of investigational sintilimab with axitinib (Inlyta) showed promise in patients with fumarate hydratase (FH)-deficient renal cell carcinoma (RCC), according to a phase II nonrandomized trial in China. Among 41… Source link : https://www.medpagetoday.com/hematologyoncology/renalcellcarcinoma/117022 Author : Publish date : 2025-08-15 18:21:00 Copyright for syndicated content belongs to the linked Source.
The post Drug Combo Shows Benefits in Rare, Aggressive Kidney Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-08-15 18:21:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8